Key risks
- PE 32.8 against ROE 8.85% presents valuation-to-return misalignment; verify if earnings quality justifies the multiple.
- Margin volatility of 8+ points: OPM fell from 24.47% (Jun 2026) to 16.17% (Sep 2025)—verify input cost exposure and pricing contractual flexibility in specialty chemicals.
- Institutional interest weak: FII 3.17% and DII 1.59% trail promoter's 54.56%—verify capital-access implications if expansion capex is needed.
- Raw material and customer concentration risks typical to specialty chemicals; verify hedging coverage and top-customer revenue dependence.
Generated analysis · source review pending